Physician

Ingela Pezzolesi, M.D.

According to 2025 Medicare claims, Ingela Pezzolesi, M.D. (NPI: 1235167180) practices family practice in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1710432612; TIN: 911939739) and primary practice location at 98383-8503. Pezzolesi is affiliated with the CommonSpirit ACO I (ACO ID: A2164), participating under the MSSP model.

Pezzolesi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 615 traditional Medicare patients, billed 8,715 HCPCS/CPT codes, and received $299,161 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,053 prescription claims across 528 beneficiaries totaling $597,101 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 118 claims. Open Payments data shows 16 records totaling $189. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $152,626 to $299,161. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $21,153 and ending at $18,518.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$154K$309K2015 Medicare payment: $152,626 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $167,986 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $200,428 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $218,228 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $187,108 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $161,513 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $183,653 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $202,361 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $308,646 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $299,161 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201553411,288$152,626
201658014,123$167,986
201771415,602$200,428
201870117,383$218,228
201969112,696$187,108
20206669,567$161,513
20216637,179$183,653
20226408,625$202,361
202363110,267$308,646
20246158,715$299,161

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$299K$597K2015 Drug cost: $373,791 (USD; Tot_Drug_Cst)2016 Drug cost: $409,117 (USD; Tot_Drug_Cst)2017 Drug cost: $450,100 (USD; Tot_Drug_Cst)2018 Drug cost: $408,584 (USD; Tot_Drug_Cst)2019 Drug cost: $401,354 (USD; Tot_Drug_Cst)2020 Drug cost: $448,903 (USD; Tot_Drug_Cst)2021 Drug cost: $419,542 (USD; Tot_Drug_Cst)2022 Drug cost: $361,260 (USD; Tot_Drug_Cst)2023 Drug cost: $451,754 (USD; Tot_Drug_Cst)2024 Drug cost: $597,101 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152755,470$373,791
20162905,288$409,117
20173555,726$450,100
20183375,496$408,584
20193495,713$401,354
20203796,068$448,903
20213825,958$419,542
20224156,085$361,260
20234406,400$451,754
20245288,053$597,101

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.2K$12K2015 Medicare payment: $11,713 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,692 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $5,298 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $11,482 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $12,494 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,366 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,026 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,914 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,765 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,257 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201583408$11,713
201688315$4,692
201782348$5,298
201884355$11,482
201962233$12,494
202059167$3,366
202149152$2,026
20222197$3,914
20233694$5,765
202417118$2,257

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit391391$129
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more418652$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more356535$53
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's231333$12
81003Automated urinalysis test7796$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MounjaroTirzepatide853,004$103,476
FarxigaDapagliflozin Propanediol452,580$48,317
JardianceEmpagliflozin271,996$39,557
JanuviaSitagliptin Phosphate362,410$39,524
XareltoRivaroxaban331,746$32,816

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0656Segmental pneumatic appliance for use with pneumatic compressor, trunkYN/R14$695
E0630Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)YN/R18$612
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsN1746$553
K0001Standard wheelchairYN/R15$218
E0940Trapeze bar, free standing, complete with grab barYN/R11$162

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$189ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ingela Pezzolesi, M.D.?

Tedicare shows public-source Medicare data for Ingela Pezzolesi, M.D. (NPI 1235167180), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ingela Pezzolesi, M.D. have ACO affiliation data?

Ingela Pezzolesi, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164).

What billing organization is linked to Ingela Pezzolesi, M.D.?

Ingela Pezzolesi, M.D. is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1710432612) in the available physician profile data.

Does Ingela Pezzolesi, M.D. have Open Payments data?

Ingela Pezzolesi, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.